[go: up one dir, main page]

Scherer et al., 1996 - Google Patents

The influence of C1-esterase inhibitor substitution on coagulation and cardiorespiratory parameters in an endotoxin-induced rabbit model of hypercoagulability

Scherer et al., 1996

Document ID
13287781297608776773
Author
Scherer R
Giebler R
Schmidt U
Paar D
Kox W
Publication year
Publication venue
Seminars in thrombosis and hemostasis

External Links

Snippet

In a short-time model of endotoxininduced (lipopolysaccharide from Escherichia coli, 120 μg kg-1 iv) hypercoagulability in rabbits, the therapeutic effects of C 1-esterase inhibitor (C 1 I) substitution (bolus 400 U kg-1 iv followed by continuous infusion of 400 U kg-1 4 h-1 iv) …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Similar Documents

Publication Publication Date Title
Jacobi Pathophysiology of sepsis
Naito et al. Combination of polycarboxybetaine coating and factor XII inhibitor reduces clot formation while preserving normal tissue coagulation during extracorporeal life support
Faymonville et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans
Pereira et al. The management of abnormalities of hemostasis in acute liver failure
Vervloet et al. Derangements of coagulation and fibrinolysis in critically III patients with sepsis and septic shock
US7153473B2 (en) Hemostatic system and components for extracorporeal circuit
AU748417B2 (en) Methods for treating hypercoagulable states or acquired protein C deficiency
Scherer et al. The influence of C1-esterase inhibitor substitution on coagulation and cardiorespiratory parameters in an endotoxin-induced rabbit model of hypercoagulability
AU735258B2 (en) Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation
Kemkes-Matthes et al. Protein Z deficiency: a new cause of bleeding tendency
Mythen et al. Postoperative multiple organ dysfunction syndrome associated with gut mucosal hypoperfusion, increased neutrophil degranulation and C1-esterase inhibitor depletion
JP2001513576A (en) Process for inhibiting complement activation via the collateral pathway
Giebler et al. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin
Turner-Gomes et al. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease
Kario et al. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis
Jourdain et al. Effects of inter-α-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation
Binder et al. Effect of heparin or fibrinogen depletion on lung fluid balance in sheep after emboli
Eriksson et al. Effect of dextran on plasma tissue plasminogen activator (t‐PA) and plasminogen activator inhibitor‐1 (PAI‐1) during surgery
Hsu et al. Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery
JP2004527554A (en) Modified FVII in ARDS processing
Kaido et al. Pretreatment with soluble thrombomodulin prevents intrasinusoidal coagulation and liver dysfunction following extensive hepatectomy in cirrhotic rats
JP3845112B2 (en) Pharmaceutical composition containing interleukin-6 and use of said pharmaceutical composition for the treatment of debilitating blood clot bleeding disorders
Balldin et al. Influence of Plasma Protease Inhibitors and Trasylol on Trypsin-Induced Bradykinin-Release in vitro and in vivo: Protease Inhibitors and Trypsin-Induced Bradykinin Release
Cardigan et al. Haemostatic changes in the pulmonary blood during cardiopulmonary bypass
Kyogashima et al. Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model